PATIENTS

How to access innovative treatments by FindMeCure Foundation

FindMeCure Widget  Medical science has been rapidly advancing in the recent decades and we can prove that with many examples: new therapies for diabetes, the first vaccine for the prevention of cervical cancer, oral treatments for Hepatitis C curing more than 90% of the cases, the first Lupus drug in 50 years, personalized medicines to […]

How to access innovative treatments by FindMeCure Foundation Read More »

Put Patients First in Headache Treatment

Put Patients First in Headache Treatment: Stephani Sutherland, PhD, is a neuroscientist, yogi, and freelance writer in Southern California.  Migraine and other severe headache disorders affect about a billion people worldwide each year, but awareness of these conditions is insufficient, and sufferers are often stigmatized by healthcare providers and by society in general. As a

Put Patients First in Headache Treatment Read More »

Migraine Day of Action

This year Migraine Day of Action will be held on September 12th and EMHA has created an initiative called #MigraineBrighterFuture What is #MigraineBrighterFuture? It´s an online campaign which involves patients all around the globe and everybody who would like to help on raising awareness about Migraine. How to participate? September 12th participants will need to upload

Migraine Day of Action Read More »

Women and Migrain

Women and Migraine Women and migraine: Estrogen may explain why women suffer more often migraines Spanish researchers have discovered that the role of this sex hormone around the trigeminal nerve could be key in migraine episodes, which could explain why woman suffer from them more often.  Sex hormones could play a key role in the

Women and Migrain Read More »

New Aimovig Medication Approved

Novartis marks a new era for migraine patients with the EU approval of Aimovig®, a first-of-its- kind treatment specifically designed for migraine prevention Jul 30, 2018 New Aimovig Medication Approved Novartis announced today that the European Commission (EC) approved Aimovig® (erenumab) for the prevention of migraine in adults experiencing four or more migraine days per month.

New Aimovig Medication Approved Read More »

The science of migraine

Why is migraine still a big mystery to science Very common especially in women, these intense headaches are still a great medical mystery whose causes are not enlightened. Very common especially in women, these intense headaches are still a great medical mystery whose causes are not enlightened. Migraines are always related to a “simple headache”,

The science of migraine Read More »

Migraine and teenagers

11.3% of Spanish teenagers suffer from migraine headaches Migraine and teenagers The journal Cephalalgia – the scientific publication of the International Society of Headaches – has just published a study by members of the Headache Study Group of the Spanish Society of Neurology (SEN) of the Vall D’Hebron University Hospital, whose Objective was to evaluate

Migraine and teenagers Read More »

Scroll to Top
Search
Close this search box.